ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Freeline Therapeutics Holdings Limited

Freeline Therapeutics Holdings Limited is an active company incorporated on 3 April 2020 with the registered office located in Stevenage, Hertfordshire. Freeline Therapeutics Holdings Limited was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12546479
Private limited company
Age
5 years
Incorporated 3 April 2020
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 2 April 2025 (9 months ago)
Next confirmation dated 2 April 2026
Due by 16 April 2026 (3 months remaining)
Last change occurred 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
Sycamore House
Gunnels Wood Road
Stevenage
Hertfordshire
SG1 2BP
England
Address changed on 16 Dec 2022 (3 years ago)
Previous address was Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage SG1 2FX United Kingdom
Telephone
01438 906870
Email
Unreported
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Director • Cfo • American • Lives in United States • Born in Apr 1970
Director • Chief Executive Officer • American • Lives in United States • Born in Apr 1974
Director • Chief Technical Operations Officer • American • Lives in United States • Born in Feb 1968
Spur Therapeutics Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Swanbio Therapeutics Limited
James Albert Bircher Iii, Michael John Parini, and 1 more are mutual people.
Active
Spur Therapeutics Limited
Michael John Parini is a mutual person.
Active
Freeline Holdings (UK) Limited
Michael John Parini is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£1.67M
Decreased by £17.32M (-91%)
Turnover
Unreported
Decreased by £488K (-100%)
Employees
Unreported
Decreased by 73 (-100%)
Total Assets
£29.69M
Decreased by £7.22M (-20%)
Total Liabilities
-£11.33M
Decreased by £7.86M (-41%)
Net Assets
£18.35M
Increased by £644K (+4%)
Debt Ratio (%)
38%
Decreased by 13.84% (-27%)
Latest Activity
Subsidiary Accounts Submitted
2 Months Ago on 20 Oct 2025
Confirmation Submitted
8 Months Ago on 30 Apr 2025
Bidco 1354 Limited (PSC) Details Changed
1 Year 3 Months Ago on 27 Sep 2024
Charge Satisfied
1 Year 4 Months Ago on 22 Aug 2024
Charge Satisfied
1 Year 4 Months Ago on 22 Aug 2024
Charge Satisfied
1 Year 4 Months Ago on 22 Aug 2024
Group Accounts Submitted
1 Year 7 Months Ago on 22 May 2024
Confirmation Submitted
1 Year 7 Months Ago on 21 May 2024
Confirmation Submitted
1 Year 7 Months Ago on 21 May 2024
Syncona Limited (PSC) Resigned
1 Year 8 Months Ago on 15 Apr 2024
Get Credit Report
Discover Freeline Therapeutics Holdings Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement by Directors
Submitted on 4 Dec 2025
Statement of capital on 4 December 2025
Submitted on 4 Dec 2025
Solvency Statement dated 03/12/25
Submitted on 4 Dec 2025
Resolutions
Submitted on 4 Dec 2025
Audit exemption subsidiary accounts made up to 31 December 2024
Submitted on 20 Oct 2025
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Submitted on 10 Oct 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Submitted on 10 Oct 2025
Consolidated accounts of parent company for subsidiary company period ending 31/12/24
Submitted on 10 Oct 2025
Confirmation statement made on 2 April 2025 with updates
Submitted on 30 Apr 2025
Change of details for Bidco 1354 Limited as a person with significant control on 27 September 2024
Submitted on 10 Oct 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year